| Year |
Title |
Altmetric |
| 2020
|
Fibroblast Growth Factor 23 and the Last Mile.
2020
|
|
| 2020
|
Ambulatory Blood Pressure Phenotypes in Adults Taking Antihypertensive Medication with and without CKD
2020
|
|
| 2020
|
APOL1 Nephropathy Risk Alleles and Mortality in African American Adults: A Cohort Study
2020
|
|
| 2020
|
Burosumab in tumor-induced osteomalacia: A case report
2020
|
|
| 2019
|
Apol1 nephropathy risk alleles and risk of sepsis in blacks
2019
|
|
| 2019
|
Race, Natriuretic Peptides, and High-Carbohydrate Challenge: A Clinical Trial
2019
|
|
| 2019
|
Association of 25-hydroxyvitamin D with incident coronary heart disease in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study
2019
|
|
| 2019
|
Race-based demographic, anthropometric and clinical correlates of N-terminal-pro B-type natriuretic peptide
2019
|
|
| 2019
|
Plasma 25-Hydroxyvitamin D and the Longitudinal Risk of Sepsis in the REGARDS Cohort
2019
|
|
| 2019
|
Association of Urine Albumin Excretion With Incident Heart Failure Hospitalization in Community-Dwelling Adults
2019
|
|
| 2019
|
Brief Report: Kidney Dysfunction Does Not Contribute Significantly to Antiretroviral Therapy Modification in Treatment-Naive PLWH Receiving Initial ART
2019
|
|
| 2019
|
Dietary Patterns and Incident Heart Failure in U.S. Adults Without Known Coronary Disease
2019
|
|
| 2019
|
Risks of anticoagulation in patients with chronic kidney disease and atrial fibrillation: More than just bleeding?
2019
|
|
| 2019
|
Relationship of Estimated GFR and Albuminuria to Concurrent Laboratory Abnormalities: An Individual Participant Data Meta-analysis in a Global Consortium
2019
|
|
| 2019
|
A PheWAS study of a large observational epidemiological cohort of African Americans from the REGARDS study
2019
|
|
| 2019
|
APOL1 kidney risk variants and cardiovascular disease: An individual participant data meta-analysis
2019
|
|
| 2019
|
Adiposity and risk of decline in glomerular filtration rate: Meta-analysis of individual participant data in a global consortium
2019
|
|
| 2019
|
Racial differences in the association of NT-proBNP with risk of incident heart failure in REGARDS
2019
|
|
| 2018
|
Adherence to Mediterranean-style diet and risk of sepsis in the REasons for Geographic and Racial Differences in Stroke (REGARDS) cohort
2018
|
|
| 2018
|
The Role of Vitamin D in CKD Stages 3 to 4: Report of a Scientific Workshop Sponsored by the National Kidney Foundation
2018
|
|
| 2018
|
Serum albumin concentration and risk of end-stage renal disease: The REGARDS study
2018
|
|
| 2018
|
Serum Calcitriol Concentrations and Kidney Function Decline, Heart Failure, and Mortality in Elderly Community-Living Adults: The Health, Aging, and Body Composition Study
2018
|
|
| 2018
|
Urinary Biomarkers of Kidney Tubular Damage and Risk of Cardiovascular Disease and Mortality in Elders
2018
|
|
| 2018
|
FGF23 (fibroblast growth factor-23) and incident hypertension in young and middle-aged adults: The CARDIA study
2018
|
|
| 2018
|
Association of serum albumin levels with kidney function decline and incident chronic kidney disease in elders
2018
|
|
| 2018
|
Dietary Oxidative Balance Scores and Biomarkers of Inflammation among Individuals with and without Chronic Kidney Disease
2018
|
|
| 2018
|
Fibroblast Growth Factor 23: A Biomarker of Kidney Function Decline
2018
|
|
| 2018
|
Association of fibroblast growth factor 23 with risk of incident coronary heart disease in community-living adults
2018
|
|
| 2018
|
APOL1 nephropathy risk variants do not associate with subclinical atherosclerosis or left ventricular mass in middle-aged black adults
2018
|
|
| 2018
|
Effect of calcitriol on serum hepcidin in individuals with chronic kidney disease: A randomized controlled trial
2018
|
|
| 2018
|
Racial differences in plasma levels of n-Terminal pro-b-Type natriuretic peptide and outcomes the reasons for geographic and racial differences in stroke (regards) study
2018
|
|
| 2018
|
The Association between Residence in a Food Desert Census Tract and Adherence to Dietary Patterns in the REGARDS Cohort.
2018
|
|
| 2017
|
Association between APOL1 genotypes and risk of cardiovascular disease in MESA (Multi-Ethnic Study of Atherosclerosis)
2017
|
|
| 2017
|
KDOQI US Commentary on the 2017 KDIGO Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD)
2017
|
|
| 2017
|
APOL1 genetic variants are not associated with longitudinal blood pressure in young black adults
2017
|
|
| 2017
|
Urinary Markers of Fibrosis and Risk of Cardiovascular Events and Death in Kidney Transplant Recipients: The FAVORIT Trial
2017
|
|
| 2017
|
Global cardiovascular and renal outcomes of reduced GFR
2017
|
|
| 2017
|
Sickle cell trait and the risk of ESRD in blacks
2017
|
|
| 2017
|
Association between soluble klotho and change in kidney function: The health aging and body composition study
2017
|
|
| 2017
|
Oxidative Balance Score and the Risk of End-Stage Renal Disease and Cardiovascular Disease
2017
|
|
| 2017
|
BP control and long-term risk of ESRD and mortality
2017
|
|
| 2017
|
Albuminuria, kidney function, and sudden cardiac death: Findings from The Reasons for Geographic and Racial Differences in Stroke (REGARDS) study
2017
|
|
| 2017
|
Association of urinary uromodulin with kidney function decline and mortality: The health ABC study
2017
|
|
| 2016
|
Response by Gutiérrez et al to letter regarding article, "Hemoglobin concentration and risk of incident stroke in community-living adults"
2016
|
|
| 2016
|
Vitamin D, Fibroblast growth factor 23 and incident cognitive impairment: Findings from the REGARDS study
2016
|
|
| 2016
|
Associations of 25-hydroxyvitamin D with markers of inflammation, insulin resistance and obesity in black and white community-dwelling adults
2016
|
|
| 2016
|
Associations of blood pressure, sunlight, and Vitamin D in community-dwelling adults
2016
|
|
| 2016
|
Hemoglobin Concentration and Risk of Incident Stroke in Community-Living Adults
2016
|
|
| 2016
|
Connecting the dots on fibroblast growth factor 23 and left ventricular hypertrophy
2016
|
|
| 2016
|
Disorders of Iron Metabolism and Anemia in Chronic Kidney Disease
2016
|
|
| 2016
|
Admixture mapping of serum vitamin D and parathyroid hormone concentrations in the African American-Diabetes Heart Study
2016
|
|
| 2016
|
Fibroblast growth factor 23 and heart failure: The plot thickens
2016
|
|
| 2016
|
Genetic african ancestry and markers of mineral metabolism in CKD
2016
|
|
| 2016
|
APOL1 nephropathy risk variants are associated with altered high-density lipoprotein profiles in African Americans
2016
|
|
| 2016
|
The role of cystatin-C in the confirmation of reduced glomerular filtration rate among the oldest old
2016
|
|
| 2016
|
Association of reduced eGFR and albuminuria with serious fall injuries among older adults
2016
|
|
| 2016
|
Vitamin D deficiency and incident stroke risk in community-living black and white adults
2016
|
|
| 2016
|
Waist Circumference, Body Mass Index, and ESRD in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study
2016
|
|
| 2015
|
Oxidative Balance Score and Chronic Kidney Disease
2015
|
|
| 2015
|
Impact of phosphorus-based food additives on bone and mineral metabolism
2015
|
|
| 2015
|
Validation of an albuminuria self-assessment tool in the Multi-Ethnic Study of Atherosclerosis (MESA)
2015
|
|
| 2015
|
Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: A collaborative meta-analysis of individual participant data
2015
|
|
| 2015
|
Diet patterns and risk of sepsis in community-dwelling adults: A cohort study
2015
|
|
| 2015
|
Obesity, metabolic health, and the risk of end-stage renal disease
2015
|
|
| 2015
|
APOL1 G1 genotype modifies the association between HDLC and kidney function in African Americans
2015
|
|
| 2015
|
Cystatin C and long term risk of community-acquired sepsis: A population-based cohort study Epidemiology and Health Outcomes
2015
|
|
| 2015
|
Associations of fibroblast growth factor-23 with markers of inflammation, insulin resistance and obesity in adults
2015
|
|
| 2015
|
Fibroblast growth factor 23 and risk of incident stroke in community-living adults
2015
|
|
| 2015
|
Bone mineral content as a driver of energy expenditure in prepubertal and early pubertal boys
2015
|
|
| 2015
|
Circulating levels of fibroblast growth factor-21 increase with age independently of body composition indices among healthy individuals
2015
|
|
| 2015
|
Contextual poverty, nutrition, and chronic kidney disease
2015
|
|
| 2015
|
Contrasting cholesterol management guidelines for adults with CKD
2015
|
|
| 2015
|
Fibroblast growth factor-21, body composition, and insulin resistance in pre-pubertal and early pubertal males and females
2015
|
|
| 2015
|
Prehospitalization risk factors for acute kidney injury during hospitalization for serious infections in the REGARDS cohort
2015
|
|
| 2015
|
Response to Letter Regarding Article, "fibroblast Growth Factor 23 and Risk of Incident Stroke in Community-Living Adults"
2015
|
|
| 2015
|
Validation study of medicare claims to identify older US adults with CKD using the reasons for geographic and racial differences in stroke (REGARDS) study
2015
|
|
| 2014
|
Reply to MF McCarty
2014
|
|
| 2014
|
High dietary phosphorus intake is associated with all-cause mortality: Results from NHANES III1-3
2014
|
|
| 2014
|
Contribution of Food Additives to Sodium and Phosphorus Content of Diets Rich in Processed Foods
2014
|
|
| 2014
|
Dietary patterns and risk of death and progression to ESRD in individuals with CKD: A cohort study
2014
|
|
| 2014
|
Incident ESRD and treatment-resistant hypertension: The reasons for geographic and racial differences in stroke (REGARDS) study
2014
|
|
| 2014
|
Low income, community poverty and risk of end stage renal disease
2014
|
|
| 2014
|
N-terminal pro-B-type natriuretic peptide and stroke risk: The reasons for geographic and racial differences in stroke cohort
2014
|
|
| 2014
|
Nondisease-specific problems and all-cause mortality among older adults with CKD: The REGARDS study
2014
|
|
| 2014
|
The association between race and income on riskof mortality in patients with moderate chronic kidney disease
2014
|
|
| 2013
|
Metabolic subtypes and risk of mortality in normal weight, overweight, and obese individuals with CKD
2013
|
|
| 2013
|
Dietary patterns are associated with incident stroke and contribute to excess risk of stroke in black americans
2013
|
|
| 2013
|
Prevalence of apparent treatment-resistant hypertension among individuals with CKD
2013
|
|
| 2013
|
Fibroblast growth factor 23, vitamin d, and health disparities among african americans with chronic kidney disease
2013
|
|
| 2013
|
Association between urinary albumin excretion and coronary heart disease in black vs white adults
2013
|
|
| 2013
|
Cardiovascular risk factors in CKD associate with both ESRD and mortality
2013
|
|
| 2013
|
Effects of dietary phosphate restriction and phosphate binders on FGF23 levels in CKD
2013
|
|
| 2013
|
α-Klotho and kidney function decline: An important step forward in understanding the link between mineral metabolism and kidney disease progression
2013
|
|
| 2013
|
Fibroblast Growth Factor 23, Klotho, and Disordered Mineral Metabolism in Chronic Kidney Disease: Unraveling the Intricate Tapestry of Events and Implications for Therapy
2013
|
|
| 2013
|
Geographic variation in CKD prevalence and ESRD incidence in the united states: Results from the reasons for geographic and racial differences in stroke (REGARDS) study
2013
|
|
| 2013
|
Healthy behaviors, risk factor control and awareness of chronic kidney disease
2013
|
|
| 2013
|
Sodium- and Phosphorus-Based Food Additives: Persistent but Surmountable Hurdles in the Management of Nutrition in Chronic Kidney Disease
2013
|
|
| 2013
|
Associations of Dietary Phosphorus Intake, Urinary Phosphate Excretion, and Fibroblast Growth Factor 23 With Vascular Stiffness in Chronic Kidney Disease
2013
|
|
| 2013
|
Chronic Kidney Disease in African Americans: Past, Present, and Future: Introduction
2013
|
|
| 2013
|
Fibroblast growth factor 23, high-sensitivity cardiac troponin, and left ventricular hypertrophy in CKD
2013
|
|
| 2013
|
Risk for recurrent coronary heart disease and all-cause mortality among individuals with chronic kidney disease compared with diabetes mellitus, metabolic syndrome, and cigarette smokers
2013
|
|
| 2013
|
The connection between dietary phosphorus, cardiovascular disease, and mortality: Where we stand and what we need to know
2013
|
|
| 2012
|
Racial differences in albuminuria, kidney function, and risk of stroke
2012
|
|
| 2012
|
Statement of concern about a commercial assay used to measure soluble hemojuvelin in humans
2012
|
|
| 2012
|
Associations of Socioeconomic Status and Processed Food Intake With Serum Phosphorus Concentration in Community-Living Adults: The Multi-Ethnic Study of Atherosclerosis (MESA)
2012
|
|
| 2012
|
High-dose cholecalciferol reduces parathyroid hormone in patients with early chronic kidney disease: A pilot, randomized, double-blind, placebo-controlled trial
2012
|
|
| 2012
|
Prevalence and prognosis of unrecognized myocardial infarctions in chronic kidney disease
2012
|
|
| 2012
|
Blood pressure indexes and end-stage renal disease risk in adults with chronic kidney disease
2012
|
|
| 2012
|
Tubular markers are associated with decline in kidney function in proteinuric type 2 diabetic patients
2012
|
|
| 2012
|
Earlier onset and greater severity of disordered mineral metabolism in diabetic patients with chronic kidney disease
2012
|
|
| 2012
|
(1-34) parathyroid hormone infusion acutely lowers fibroblast growth factor 23 concentrations in adult volunteers
2012
|
|
| 2011
|
Age-specific associations of reduced estimated glomerular filtration rate with concurrent chronic kidney disease complications
2011
|
|
| 2011
|
Fibroblast growth factor 23, cardiovascular disease risk factors, and phosphorus intake in the health professionals follow-up study
2011
|
|
| 2011
|
Recent insights into racial differences in bone and mineral metabolism
2011
|
|
| 2011
|
FGF23 induces left ventricular hypertrophy
2011
|
|
| 2011
|
Vitamin D Deficiency, Inflammation, and Albuminuria in Chronic Kidney Disease: Complex Interactions
2011
|
|
| 2011
|
Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease
2011
|
|
| 2011
|
Racial differences in the relationship between vitamin D, bone mineral density, and parathyroid hormone in the National Health and Nutrition Examination Survey
2011
|
|
| 2011
|
Increased serum phosphate and adverse clinical outcomes: Unraveling mechanisms of disease
2011
|
|
| 2011
|
Diuretics, calciuria and secondary hyperparathyroidism in the Chronic Renal Insufficiency Cohort
2011
|
|
| 2011
|
Impact of Poverty on Serum Phosphate Concentrations in the Third National Health and Nutrition Examination Survey
2011
|
|
| 2011
|
Pilot study of dietary phosphorus restriction and phosphorus binders to target fibroblast growth factor 23 in patients with chronic kidney disease
2011
|
|
| 2011
|
Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease
2011
|
|
| 2011
|
Hepcidin and disordered mineral metabolism in chronic kidney disease
2011
|
|
| 2010
|
Racial differences in postprandial mineral ion handling in health and in chronic kidney disease
2010
|
|
| 2010
|
Low socioeconomic status associates with higher serum phosphate irrespective of race
2010
|
|
| 2010
|
Fibroblast growth factor 23 and disordered vitamin D metabolism in chronic kidney disease: Updating the "trade-off" hypothesis
2010
|
|
| 2010
|
Dietary phosphorus restriction in advanced chronic kidney disease: Merits, challenges, and emerging strategies
2010
|
|
| 2010
|
Vitamin D deficiency and anemia in early chronic kidney disease
2010
|
|
| 2010
|
Response to Targeting hyperphosphatemia: Truth or dare
2010
|
|
| 2010
|
The authors reply
2010
|
|
| 2010
|
The authors reply
2010
|
|
| 2009
|
A blueprint for randomized trials targeting phosphorus metabolism in chronic kidney disease
2009
|
|
| 2009
|
Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease
2009
|
|
| 2009
|
Plasma gelsolin and circulating actin correlate with hemodialysis mortality
2009
|
|
| 2009
|
Phosphorus binders and survival on hemodialysis
2009
|
|
| 2008
|
Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis
2008
|
|
| 2008
|
N-terminal pro-B-type natriuretic peptide (NT-proBNP) concentrations in hemodialysis patients: Prognostic value of baseline and follow-up measurements
2008
|
|
| 2008
|
Impact of activated vitamin D and race on survival among hemodialysis patients
2008
|
|
| 2008
|
Postprandial mineral metabolism and secondary hyperparathyroidism in early CKD
2008
|
|
| 2008
|
Prevalence and severity of disordered mineral metabolism in Blacks with chronic kidney disease
2008
|
|
| 2007
|
Vitamin D levels and early mortality among incident hemodialysis patients
2007
|
|
| 2007
|
Emphysematous pyelonephritis
2007
|
|
| 2007
|
Refractory hyponatremia
2007
|
|
| 2006
|
Post-transplant hypophosphatemia: Tertiary 'Hyper-Phosphatoninism'?
2006
|
|
| 2005
|
Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease
2005
|
|
| 1999
|
CACP, encoding a secreted proteoglycan, is mutated in camptodactyly- arthropathy-coxa vara-pericarditis syndrome
1999
|
|
